Abbott Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Life Science News

MiniMed Go Smart Diabetes Management System from Medtronic Gets FDA Clearance

January 20, 2026

Abbott’s Tendyne System Receives FDA Nod for High-Risk Mitral Valve Patients

Top Medical Device Companies to Work For in Canada in 2025, According to Forbes

February 28, 2025

Top 20 Publicly Traded Medical Device Companies by Market Cap in 2025

February 24, 2025

Top 10 Largest MedTech Mergers and Acquisitions of the Decade

January 7, 2025

Clinical Trial News

Abbott Launches Trial to Assess Early Use of HeartMate 3 for Advanced Heart Failure

October 25, 2024

Top 10 Largest Publicly Traded Medical Device Companies by Market Cap in 2024

September 9, 2024

Healthcare News

Abbott’s FreeStyle Libre CGM Meets Medtronic’s Insulin Delivery

August 13, 2024

Top 10 Best Medical Device/Medtech Companies to Work For in 2024, According to Forbes

Abbott’s HPV Test Gets FDA Approval for High-Risk HPV Detection and Cervical Cancer Screening

November 9, 2023

Top 10 Medical Device Companies in 2023: Statistics and Trends

Abbott’s Proclaim Plus Spinal Cord Stimulation System Clenches FDA Approval

August 24, 2022

Freestyle Libre 3 By Abbott Gets FDA Clearance and Becomes the Affordable Continuous Glucose Monitor

Clinical Trial News

Abbott Builds Upon Diversity in Clinical Trials Initiative by Partnering with Women as One

Abbott’s New Leadless Pacemaker Receives FDA Approval for Slow Heart Rhythms

Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System – Xtalks Life Science Podcast Ep. 44

January 19, 2022

Next Page »